AAA

Affinity Asset Advisors Portfolio holdings

AUM $1.39B
1-Year Est. Return 230.19%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+230.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$399M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
110
New
Increased
Reduced
Closed

Top Buys

1
+$54.2M
2
+$18.4M
3
+$15.9M
4
SLNO icon
Soleno Therapeutics
SLNO
+$14.8M
5
CYTK icon
Cytokinetics
CYTK
+$14.4M

Top Sells

1
+$32M
2
+$12.5M
3
+$8.84M
4
INZY
Inozyme Pharma
INZY
+$7M
5
VERA icon
Vera Therapeutics
VERA
+$5.59M

Sector Composition

1 Healthcare 91.07%
2 Financials 0.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OVID icon
51
Ovid Therapeutics
OVID
$115M
$3.44M 0.32%
2,650,000
+1,982,484
BBIO icon
52
BridgeBio Pharma
BBIO
$12.6B
$3.38M 0.31%
65,000
-85,000
JAZZ icon
53
Jazz Pharmaceuticals
JAZZ
$11.5B
$3.29M 0.31%
25,000
CRNX icon
54
Crinetics Pharmaceuticals
CRNX
$4.14B
$3.12M 0.29%
75,000
-77,252
MBX
55
MBX Biosciences
MBX
$1.43B
$2.89M 0.27%
+165,000
AUTL
56
Autolus Therapeutics
AUTL
$431M
$2.85M 0.27%
1,750,000
-1,295,000
OCUL icon
57
Ocular Therapeutix
OCUL
$2.34B
$2.79M 0.26%
+239,000
OACCU
58
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
$2.66M 0.25%
250,000
CLYM
59
Climb Bio
CLYM
$473M
$2.61M 0.24%
1,300,000
-200,000
OLMA icon
60
Olema Pharmaceuticals
OLMA
$1.85B
$2.45M 0.23%
250,000
SGMT icon
61
Sagimet Biosciences
SGMT
$179M
$2.4M 0.22%
+350,000
ATXS
62
DELISTED
Astria Therapeutics
ATXS
$2.18M 0.2%
300,000
UTHR icon
63
United Therapeutics
UTHR
$21.8B
$2.1M 0.2%
+5,000
GERN icon
64
Geron
GERN
$932M
$2.06M 0.19%
1,500,000
AVR
65
Anteris Technologies
AVR
$642M
$2.02M 0.19%
450,000
+25,000
OBIO icon
66
Orchestra BioMed
OBIO
$246M
$1.8M 0.17%
+727,272
EPRX
67
Eupraxia Pharmaceuticals
EPRX
$411M
$1.77M 0.16%
+300,000
CGEM icon
68
Cullinan Oncology
CGEM
$927M
$1.56M 0.15%
263,817
MIST icon
69
Milestone Pharmaceuticals
MIST
$143M
$1.33M 0.12%
+666,666
CMPS
70
Compass Pathways
CMPS
$775M
$1.15M 0.11%
+200,000
NXTC icon
71
NextCure
NXTC
$43.1M
$1.12M 0.1%
191,882
-1
CATX icon
72
Perspective Therapeutics
CATX
$598M
$1.03M 0.1%
300,000
-750,000
STRO icon
73
Sutro Biopharma
STRO
$325M
$654K 0.06%
75,272
JBIO
74
Jade Biosciences
JBIO
$688M
$564K 0.05%
65,317
ENGN icon
75
enGene Holdings
ENGN
$645M
$526K 0.05%
77,000
1 2
3
4 5